<DOC>
	<DOCNO>NCT02633176</DOCNO>
	<brief_summary>This Phase Ⅲ randomize , control , multi-center , trial compare cisplatin plus docetaxel cetuximab , cisplatin , docetaxel induction chemotherapy follow concurrent chemoradiation previously untreated patient metastatic nasopharyngeal carcinoma ( mNPC ) determine whether addition cetuximab induction chemotherapy chemoradiation could improve therapeutic efficacy mNPC , investigate predictive prognostic factor mNPC .</brief_summary>
	<brief_title>Cisplatin Plus Docetaxel Versus Cetuximab , Cisplatin , Docetaxel Metastatic Nasopharyngeal Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Histologically cytologically confirm nasopharyngeal carcinoma Untreated metastatic nasopharyngeal carcinoma ( stage ⅣC accord 7th American Joint Committee Cancer stag system stage ⅣB accord Chinese 2008 stag system nasopharyngeal carcinoma ) Patients must measurable disease base Response Evaluation Criteria Solid Tumors ( RECIST ) version 1.1 Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 Life expectancy least 6 month Absolute neutrophil count ( ANC ) &gt; =1.5×10^9/L Platelets &gt; = 80×10^9/L Hemoglobin &gt; = 90 g/l Bilirubin &lt; = 1.5 × upper limit normal ( ULN ) Aminopherases ( alanine transaminase aspartate aminotransferase ) &lt; = 2.5 × ULN ( without liver metastasis ) &lt; = 5.0 × ULN ( liver metastasis ) Creatinine &lt; =ULN International normalize ratio ( INR ) prothrombin time ( PT ) &lt; = 1.5 × ULN The pregnancy test woman childbearing potential negative treatment Women childbearing potential sexually active male must adopt efficient contraception method treatment six month completion treatment Patients understand willing participate study . Inform consent form suppose obtain treatment Prior radiotherapy target lesion Prior systemic chemotherapy and/or target therapy Brain metastasis Concurrent malignancy Severe active infectious disease require systemic antibiotic antiviral , antifungal treatment Active tuberculosis Severe cardiovascular disease , include uncontrolled hypertension , unstable angina , myocardial infarction past 6 month , congestive heart failure cardiac function grade Ⅲ Ⅳ base New York Heart Association cardiac functional grading , serious arrhythmia , pericardial effusion Coexisting mental disease would preclude full compliance study Females pregnant breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>